Dr. Lachelle D. Weeks is a physician-scientist at Dana-Farber Cancer Institute in the Department of Medical Oncology and an Instructor of Medicine at Harvard Medical School. She earned her MD and PhD degrees from Case Western Reserve University School of Medicine. Dr. Weeks subsequently completed her medical training at Brigham and Women’s Hospital Internal Medicine Residency and Dana-Farber Cancer Institute Hematology/Oncology Fellowship. Dr. Weeks currently directs the myeloid malignancy precursor efforts for the Dana-Farber Center for Early Detection and Interception where she counsels patients who have clonal hematopoiesis. As an independent investigator in the Division of Population Sciences, Dr. Weeks’s translational laboratory focuses on identifying risk factors for clonal hematopoiesis, understanding clinical and molecular features that predict risk of progression to overt malignancy, and designing strategies for early intervention to prevent adverse outcomes. Her work is supported by the American Society of Hematology, Robert Wood Johnson Foundation, Edward P. Evans Foundation for MDS, Wood Foundation, and Breakthrough Cancer.